Argenx
ARGX
$987.69
Share price
-0.92%
Change (1 day)
53.36%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
EPS for Argenx (ARGX)
EPS in 2023 (TTM): -$6.80
According to Argenx 's latest financial reports the company's current EPS (TTM) is -$7.47. In 2022 the company made an earnings per share (EPS) of -$23.56.
EPS history for Argenx from 2022 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$6.80 | -71.13% |
| 2022 | -$23.56 |